C. Bredeson

发表

Transplantation for autoimmune diseases in north and South America: a report of the Center for International Blood and Marrow Transplant Research.

H. Atkins, K. Sullivan, M. Pasquini, 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Autologous Hematopoietic Cell Transplantation for Treatment-Refractory Relapsing Multiple Sclerosis: Position Statement from the American Society for Blood and Marrow Transplantation.

Jeffrey A. Cohen, H. Atkins, K. Sullivan, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

A single-institution analysis of the utility of pre-induction ejection fraction measurement in patients newly diagnosed with acute myeloid leukemia

H. Atkins, D. Allan, B. Zanke, 2015, Leukemia & lymphoma.

Peripheral-blood stem cells versus bone marrow from unrelated donors.

P. Westervelt, S. Mineishi, D. Porter, 2012, The New England journal of medicine.

Feasibility of allogeneic hematopoietic stem cell transplantation for autoimmune disease: position statement from a National Institute of Allergy and Infectious Diseases and National Cancer Institute-Sponsored International Workshop, Bethesda, MD, March 12 and 13, 2005.

M. Mayes, B. Sandmaier, Roland Martin, 2005, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Autologous Hematopoietic Stem Cell Transplantation for Liver Transplant Recipients With Recurrent Primary Sclerosing Cholangitis: A Pilot Study

H. Atkins, D. Allan, A. Humar, 2021, Transplantation.

Autologous stem cell transplantation for stiff person syndrome: two cases from the Ottawa blood and marrow transplant program.

H. Atkins, D. Allan, L. Huebsch, 2014, JAMA neurology.

Dead space ventilation parallels changes in scintigraphic vascular obstruction at recurrence of pulmonary embolism and after thrombolytic therapy: a case report.

M. Rodger, L. Huebsch, C. Bredeson, 1998, Canadian respiratory journal.

Effect of age on outcome of reduced-intensity hematopoietic cell transplantation for older patients with acute myeloid leukemia in first complete remission or with myelodysplastic syndrome.

J. Sierra, J. Dipersio, B. George, 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

GRFS and CRFS in alternative donor hematopoietic cell transplantation for pediatric patients with acute leukemia.

M. Aljurf, J. Szer, R. Gale, 2019, Blood advances.

Long-term survival and late deaths after allogeneic bone marrow transplantation. Late Effects Working Committee of the International Bone Marrow Transplant Registry.

J. V. Stone, J. Klein, J. Wingard, 1999, The New England journal of medicine.

Allogeneic Transplantation to Treat Therapy Related MDS and AML in Adults.

Christopher G. Kanakry, B. Sandmaier, C. Hourigan, 2021, Transplantation and cellular therapy.

Myeloablative Autologous Stem‐Cell Transplantation for Severe Scleroderma

M. Mayes, S. Heimfeld, K. Sullivan, 2018, The New England journal of medicine.

Prevalence of hematopoietic cell transplant survivors in the United States.

K. Kuntz, K. Robien, Stephanie J. Lee, 2013, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Plerixafor for autologous stem-cell mobilization and transplantation for patients in Ontario.

J. Kuruvilla, C. Bredeson, A. Xenocostas, 2016, Current oncology.

Fludarabine and Melphalan Compared with Reduced Doses of Busulfan and Fludarabine Improves Transplant Outcomes in Older MDS Patients.

M. Aljurf, J. Szer, R. Gale, 2021, Transplantation and cellular therapy.

Impact of Pretransplantation Renal Dysfunction on Outcomes after Allogeneic Hematopoietic Cell Transplantation.

M. Sorror, M. Krem, M. Pasquini, 2021, Transplantation and cellular therapy.

81: Performance Status, but not the Hematopoietic Cell Transplantation Comorbidity Index (HCT-CI), Predicts Mortality at a Canadian Transplant Centre

C. Bredeson, M. Seftel, A. Demers, 2008 .

Indications for Hematopoietic Cell Transplantation and Immune Effector Cell Therapy: Guidelines from the American Society for Transplantation and Cellular Therapy: Guidelines for Hematopoietic Transplantation and Cellular Therapy.

S. Crawford, P. Veys, R. Champlin, 2020, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Rationale and design of platelet transfusions in haematopoietic stem cell transplantation: the PATH pilot study

D. Allan, K. Thavorn, D. Fergusson, 2016, BMJ Open.

The bedside investigation of pulmonary embolism diagnosis study: a double-blind randomized controlled trial comparing combinations of 3 bedside tests vs ventilation-perfusion scan for the initial investigation of suspected pulmonary embolism.

I. Stiell, P. Wells, M. Rodger, 2006, Archives of internal medicine.

Conditioning regimens for allotransplants for diffuse large B-cell lymphoma: myeloablative or reduced intensity?

J. Vose, Sonali M. Smith, P. Hari, 2012, Blood.

Outcomes of both abbreviated hyper‐CVAD induction followed by autologous hematopoietic cell transplantation and conventional chemotherapy for mantle cell lymphoma: a 10‐year single‐centre experience with literature review

D. Allan, L. Huebsch, S. Mcdiarmid, 2015, Cancer medicine.

lymphoma: myeloablative or reduced intensity? Conditioning regimens for allotransplants for diffuse large B-cell

Sonali M. Smith, P. Hari, P. Armand, 2012 .

National Institutes of Health Blood and Marrow Transplant LateEffects Initiative: The Healthcare Delivery Working Group Report

Kimberly, Susan, C. Bredeson, 2017 .

National Institutes of Health Blood and Marrow Transplant Late Effects Initiative: The Healthcare Delivery Working Group Report.

M. Flowers, C. Bredeson, S. Hashmi, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Weighty choices: selecting optimal G-CSF doses for stem cell mobilization to optimize yield.

J. Wingard, T. Spitzer, B. Shaw, 2020, Blood advances.

Outcomes of allogeneic hematopoietic cell transplantation for adolescent and young adults compared with children and older adults with acute myeloid leukemia.

W. Wood, M. Horowitz, Stephanie J. Lee, 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Effectiveness and safety of thiotepa as conditioning treatment prior to stem cell transplant in patients with central nervous system lymphoma

D. Fergusson, A. Tinmouth, C. Bredeson, 2014, Leukemia & lymphoma.

Primary plasma cell leukemia: Report of 17 new cases treated with autologous or allogeneic stem‐cell transplantation and review of the literature

R. Fonseca, R. Munker, M. Nordberg, 2005, American journal of hematology.

Comparison of high doses of total body irradiation in myeloablative conditioning prior to hematopoietic cell transplantation.

M. Perales, E. Guinan, S. Mineishi, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Systemic Sclerosis as an Indication for Autologous Hematopoietic Cell Transplantation: Position Statement from the American Society for Blood and Marrow Transplantation.

K. Sullivan, L. Crofford, M. Pasquini, 2018, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Myasthenia Gravis Treated With Autologous Hematopoietic Stem Cell Transplantation.

H. Atkins, D. Allan, L. Huebsch, 2016, JAMA neurology.

Subcutaneous plasmacytomas with tropism to sites of previous trauma in a multiple myeloma patient treated with an autologous bone marrow transplant

C. Chang, M. Rosenblum, C. Bredeson, 2003, American journal of hematology.

High Dose Therapy with Autologous Hematopoietic Stem Cell Transplantation (HSCT) for Patients with Primary Systemic Amyloidosis (AL): An Abmtr Study

M. Horowitz, D. Reece, C. Bredeson, 2004 .

Genetically identical twin transplantation for chronic lymphocytic leukemia

G. Marti, W. Chan, E. Montserrat, 2007, Leukemia.

Rapamycin enriches for CD4(+) CD25(+) CD27(+) Foxp3(+) regulatory T cells in ex vivo-expanded CD25-enriched products from healthy donors and patients with multiple sclerosis.

R. Truitt, C. Bredeson, C. Keever-Taylor, 2007, Cytotherapy.

Allogeneic hematopoietic cell transplantation for diffuse large B cell lymphoma: who, when and how?

T. Kroll, T. Shea, H. Lazarus, 2014, Bone Marrow Transplantation.

Cost-effectiveness of low-molecular-weight heparin and unfractionated heparin in treatment of deep vein thrombosis.

P. Wells, M. Rodger, L. Huebsch, 1998, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

Can GCSF-stimulated donor lymphocyte infusions improve outcomes for relapsed disease following allogeneic hematopoietic cell transplantation? A systematic review and meta-analysis

D. Allan, C. Bredeson, M. Sabloff, 2022, Leukemia & lymphoma.

Network geometry of evidence from randomised controlled trials addressing donor selection and source of haematopoietic progenitor cells used in allogeneic transplantation: a systematic scoping review

D. Allan, B. Hutton, C. Bredeson, 2018, Transfusion medicine.

The mutational landscape in chronic myelomonocytic leukemia and its impact on allogeneic hematopoietic cell transplantation outcomes: a Center for Blood and Marrow Transplantation Research (CIBMTR) analysis

R. Vij, Lixin Yang, M. Aljurf, 2022, Haematologica.

Hematopoietic Cell Transplantation as Curative Therapy for Patients with Myelofibrosis: Long-Term Success in all Age Groups.

H. Deeg, P. Hari, K. Ballen, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Steady-state end-tidal alveolar dead space fraction and D-dimer: bedside tests to exclude pulmonary embolism.

P. Wells, M. Rodger, C. Bredeson, 2001, Chest.

Factors affecting neutrophil and platelet reconstitution following T cell-depleted bone marrow transplantation: differential effects of growth factor type and role of CD34+ cell dose

C. Bredeson, D. Margolis, J. Klein, 2001, Bone Marrow Transplantation.

Myeloproliferative disorder with eosinophilia and ETV6-ABL gene rearrangement: efficacy of second-generation tyrosine kinase inhibitors.

C. Bredeson, S. Kroft, E. Atallah, 2009, Leukemia research.

Bone marrow transplants from mismatched related and unrelated donors for severe aplastic anemia

H. Schrezenmeier, G. Socié, E. Gluckman, 2006, Bone Marrow Transplantation.

Autologous versus reduced-intensity allogeneic hematopoietic cell transplantation for patients with chemosensitive follicular non-Hodgkin lymphoma beyond first complete response or first partial response.

J. Vose, M. Horowitz, R. Negrin, 2011, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Contribution of chemotherapy mobilization to disease control in multiple myeloma treated with autologous hematopoietic cell transplantation

A. Krishnan, W. Wood, P. Hari, 2015, Bone Marrow Transplantation.

Autologous blood and marrow transplantation in patients 60 years and older.

H. Atkins, L. Huebsch, C. Bredeson, 2000, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

D. Horsman, J. Ragaz, C. Bredeson, 1993, Leukemia & lymphoma.

Myeloablative allogeneic hematopoietic stem cell transplantation in patients who experience relapse after autologous stem cell transplantation for lymphoma: a report of the International Bone Marrow Transplant Registry.

J. Vose, M. Horowitz, R. Gale, 2004, Blood.

Nonmyeloablative allogeneic hematopoietic cell transplantation in patients with acute myeloid leukemia.

M. Maris, R. Storb, B. Sandmaier, 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A 15-year analysis of early and late autologous hematopoietic stem cell transplant in relapsed, aggressive, transformed, and nontransformed follicular lymphoma.

H. Atkins, B. Hutton, D. Fergusson, 2007, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Reduced intensity conditioned allograft yields favorable survival for older adults with B‐cell acute lymphoblastic leukemia

B. Sandmaier, H. Khoury, O. Ringdén, 2017, American journal of hematology.

A phase 1 clinical trial of vorinostat in combination with decitabine in patients with acute myeloid leukaemia or myelodysplastic syndrome

J. Issa, P. Marks, A. Yang, 2014, British journal of haematology.

J. Szer, B. George, R. Gale, 2013, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Risk factors for acute GVHD and survival after hematopoietic cell transplantation.

M. Horowitz, R. Gale, Stephanie J. Lee, 2012, Blood.

Total Body Irradiation without Chemotherapy as Conditioning for an Allogeneic Hematopoietic Cell Transplantation for Adult Acute Myeloid Leukemia

H. Atkins, D. Allan, L. Huebsch, 2016, Case reports in hematology.

The implication of follicular lymphoma patients receiving allogeneic stem cell transplantation from donors carrying t(14;18)-positive cells

C. Chang, D. Vesole, B. Logan, 2005, Bone Marrow Transplantation.

Stem Cell Transplantation in Myelodysplastic Syndromes and Acute Myeloid Leukemia

A. Schuh, C. Bredeson, C. Kouroukis, 2012 .

The graft-versus-leukemia effect using matched unrelated donors is not superior to HLA-identical siblings for hematopoietic stem cell transplantation.

A. Barrett, M. Horowitz, J. Wingard, 2009, Blood.

Choosing Wisely BMT: American Society for Blood and Marrow Transplantation and Canadian Blood and Marrow Transplant Group's List of 5 Tests and Treatments to Question in Blood and Marrow Transplantation.

A. Krishnan, A. Viswabandya, Z. DeFilipp, 2018, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

High rate of discordance between clinical and autopsy diagnoses in blood and marrow transplantation

C. Bredeson, D. Pruthi, D. Szwajcer, 2007, Bone Marrow Transplantation.

HLA-matched sibling bone marrow transplantation for β-thalassemia major.

M. Chandy, R. Gale, A. Ghavamzadeh, 2011, Blood.

Race and ethnicity influences collection of granulocyte colony-stimulating factor-mobilized peripheral blood progenitor cells from unrelated donors, a Center for International Blood and Marrow Transplant Research analysis.

J. Wingard, B. Shaw, H. Lazarus, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Indications and Results of HLA-Identical Sibling Hematopoietic Cell Transplantation for Sickle Cell Disease.

D. Neuberg, K. Sullivan, E. Petersdorf, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Tumor load in patients with follicular lymphoma post stem cell transplantation may correlate with clinical course

C. Bredeson, C. Chang, M. Juckett, 2003, Bone Marrow Transplantation.

Nelarabine-containing regimen followed by daratumumab as an effective salvage therapy and bridge to allogeneic hematopoietic stem cell transplantation for primary refractory early T-cell precursor lymphoblastic leukemia

C. Bredeson, M. Sabloff, P. Berardi, 2021, Leukemia & lymphoma.

Heterogeneity in Studies of Mesenchymal Stromal Cells to Treat or Prevent Graft-versus-Host Disease: A Scoping Review of the Evidence.

D. Allan, C. Bredeson, N. Kekre, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

A plerixafor-based strategy allows adequate hematopoietic stem cell collection in poor mobilizers: results from the Canadian Special Access Program

D. Allan, L. Huebsch, C. Bredeson, 2014, Bone Marrow Transplantation.

Systematic review of randomized controlled trials of hematopoietic stem cell mobilization strategies for autologous transplantation for hematologic malignancies.

D. Allan, C. Bredeson, J. Tay, 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Personalizing Busulfan-Based Conditioning: Considerations from the American Society for Blood and Marrow Transplantation Practice Guidelines Committee.

A. Paci, M. Perales, M. Mohty, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Indications for Autologous and Allogeneic Hematopoietic Cell Transplantation: Guidelines from the American Society for Blood and Marrow Transplantation.

S. Crawford, P. Veys, R. Champlin, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Prospective cohort study comparing intravenous busulfan to total body irradiation in hematopoietic cell transplantation.

J. Dipersio, F. Appelbaum, M. Pasquini, 2013, Blood.

Trends in use of and survival after autologous hematopoietic cell transplantation in North America, 1995-2005: significant improvement in survival for lymphoma and myeloma during a period of increasing recipient age.

Stephanie J. Lee, P. McCarthy, H. Lazarus, 2013, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

transplantation Risk factors for acute GVHD and survival after hematopoietic cell

M. Horowitz, R. Gale, Stephanie J. Lee, 2012 .

Outcome of patients with IgD and IgM multiple myeloma undergoing autologous hematopoietic stem cell transplantation: a retrospective CIBMTR study.

H. Atkins, P. Hari, A. Dispenzieri, 2010, Clinical lymphoma, myeloma & leukemia.

Outcomes following HSCT using fludarabine, busulfan, and thymoglobulin: a matched comparison to allogeneic transplants conditioned with busulfan and cyclophosphamide.

M. Horowitz, K. Ballen, C. Bredeson, 2008, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Expression of natural killer receptors in T- and NK-cells: comparison of healthy individuals, patients with prior stem cell transplant, and patients undergoing chemotherapy

C. Bredeson, S. Kroft, B. Schur, 2010, Leukemia & lymphoma.

Significant improvement in survival after allogeneic hematopoietic cell transplantation during a period of significantly increased use, older recipient age, and use of unrelated donors.

Stephanie J. Lee, P. McCarthy, H. Lazarus, 2013, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Donor Experiences of Second Marrow or Peripheral Blood Stem Cell Collection Mirror the First, but CD34+ Yields Are Less.

J. Szer, D. Stroncek, J. Liesveld, 2018, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Intravenous Busulfan Compared with Total Body Irradiation Pretransplant Conditioning for Adults with Acute Lymphoblastic Leukemia.

B. Sandmaier, M. Horowitz, R. Gale, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

High prevalence of Dapsone-induced oxidant hemolysis in North American SCT recipients without glucose-6-phosphate-dehydrogenase deficiency

P. Hari, C. Bredeson, A. Harrington, 2012, Bone Marrow Transplantation.

Impact of conditioning regimen on outcomes for patients with lymphoma undergoing high-dose therapy with autologous hematopoietic cell transplantation.

A. Lane, M. Aljurf, M. Pasquini, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Comparable outcomes in nonsecretory and secretory multiple myeloma after autologous stem cell transplantation.

P. Hari, R. Kyle, Shaji K. Kumar, 2008, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

transplantation superior to HLA-identical siblings for hematopoietic stem cell The graft-versus-leukemia effect using matched unrelated donors is not

J. Wingard, P. McCarthy, S. Spellman, 2011 .

Payment and Care for Hematopoietic Cell Transplantation Patients: Toward a Specialized Medical Home for Complex Care Patients.

M. Mcclellan, P. Hari, K. Komanduri, 2018, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

The Use of Intravenous Antibiotics at the Onset of Neutropenia in Patients Receiving Outpatient-Based Hematopoietic Stem Cell Transplants

L. Huebsch, S. Mcdiarmid, C. Bredeson, 2012, PloS one.

A randomized trial of granulocyte colony-stimulating factor (Neupogen) starting day 1 vs day 7 post-autologous stem cell transplantation

H. Atkins, L. Huebsch, S. Mcdiarmid, 1998, Bone Marrow Transplantation.

Primary Graft Failure after Myeloablative Allogeneic Hematopoietic Cell Transplantation for Hematologic Malignancies

M. Pasquini, Xiaochun Zhu, O. Ringdén, 2015, Leukemia.

irradiation in hematopoietic cell transplantation Prospective cohort study comparing intravenous busulfan to total body

J. Dipersio, F. Appelbaum, M. Pasquini, 2013 .

Impact of conditioning regimen on outcomes for patients with lymphoma undergoing high-dose therapy with autologous hematopoietic cell transplantation.

A. Lane, M. Aljurf, M. Pasquini, 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

HLA-haploidentical vs matched unrelated donor transplants with posttransplant cyclophosphamide-based prophylaxis.

R. Soiffer, M. Grunwald, N. Ghosh, 2021, Blood.

Collection of Peripheral Blood Progenitor Cells in One Day is Associated with Decreased Donor Toxicity compared to Two Days in Unrelated Donors.

J. Wingard, J. Liesveld, T. Spitzer, 2020, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Predictors of lost to follow-up among pediatric and adult hematopoietic cell transplant survivors: A report from the Center for International Blood and Marrow Transplant Research.

W. Wood, M. Aljurf, A. Yoshimi, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Long-Term Survival and Late Deaths after Allogeneic Bone Marrow Transplantation

J. V. Stone, J. Klein, J. Wingard, 1999 .

R. Gale, M. Bishop, O. Ringdén, 2011, Bone Marrow Transplantation.

Autotransplantation versus HLA‐matched unrelated donor transplantation for acute myeloid leukaemia: a retrospective analysis from the Center for International Blood and Marrow Transplant Research

J. Klein, M. Horowitz, R. Gale, 2006, British journal of haematology.

Hematopoietic stem cell transplantation and rhinosinusitis: The utility of screening sinus computed tomography

S. Tarima, Z. Soler, C. Bredeson, 2012, The Laryngoscope.

The Sequence of Cyclophosphamide and Myeloablative Total Body Irradiation in Hematopoietic Cell Transplantation for Patients with Acute Leukemia.

F. Baron, M. Aljurf, M. Pasquini, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Performing allogeneic and autologous hematopoietic SCT in the outpatient setting: effects on infectious complications and early transplant outcomes

H. Atkins, B. Hutton, E. Sabri, 2010, Bone Marrow Transplantation.

M. Pasquini, K. Ballen, H. Lazarus, 2010, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Bone marrow transplantation for severe aplastic anemia: a randomized controlled study of conditioning regimens.

J. Klein, M. Horowitz, J. Passweg, 2007, Blood.

Hematopoietic cell transplantation after nonmyeloablative conditioning for advanced chronic lymphocytic leukemia.

J. Radich, M. Sorror, M. Maris, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Haploidentical vs sibling, unrelated, or cord blood hematopoietic cell transplantation for acute lymphoblastic leukemia

M. Krem, C. Hourigan, M. Aljurf, 2021, Blood advances.

Analysis of risk factors for the development of GVHD after T cell-depleted allogeneic BMT: effect of HLA disparity, ABO incompatibility, and method of T-cell depletion.

M. Horowitz, D. Vesole, C. Bredeson, 2001, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Intravenous versus oral busulfan-based conditioning for pediatric allogeneic hematopoietic cell transplantations: did the pendulum swing too far, too fast?

C. Bredeson, 2013, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

J. Vose, P. Hari, R. Gale, 2009, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Allogeneic transplants in follicular lymphoma: higher risk of disease progression after reduced-intensity compared to myeloablative conditioning.

J. Vose, P. Hari, R. Gale, 2008, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Bone marrow transplantation from HLA-identical siblings as treatment for myelodysplasia.

John P Klein, Daniel J Weisdorf, Ciril Rozman, 2002, Blood.

Intravenous Busulfan-Based Myeloablative Conditioning Regimens Prior to Hematopoietic Cell Transplantation for Hematologic Malignancies.

J. Mehta, J. Dipersio, S. Mineishi, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Worse outcome and more chronic GVHD with peripheral blood progenitor cells than bone marrow in HLA-matched sibling donor transplants for young patients with severe acquired aplastic anemia.

J. Klein, R. Gale, J. Passweg, 2007, Blood.

Evaluating dose-limiting toxicities of MDM2 inhibitors in patients with solid organ and hematologic malignancies: A systematic review of the literature.

H. Atkins, T. Ramsay, C. Bredeson, 2019, Leukemia research.

Outpatient autologous hematopoietic stem cell transplantation for patients with relapsed follicular lymphoma

H. Atkins, L. Huebsch, S. Mcdiarmid, 2006, Annals of Hematology.

Bone marrow transplantation for diamond-blackfan anemia.

M. Pasquini, V. Roy, C. Bredeson, 2005, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Increasing incidence of chronic graft-versus-host disease in allogeneic transplantation: a report from the Center for International Blood and Marrow Transplant Research.

Tao Wang, Thomas Spitzer, Daniel J Weisdorf, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

An evaluation of the donor experience in the canadian multicenter randomized trial of bone marrow versus peripheral blood allografting.

T. Panzarella, J. Lipton, L. Huebsch, 2004, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Risk factors for bronchiolitis obliterans in allogeneic hematopoietic stem-cell transplantation for leukemia.

J. Klein, P. Layde, M. Horowitz, 2005, Chest.

Blood and Marrow Transplant Clinical Trials Network State of the Science Symposium 2007.

F. Appelbaum, H. Heslop, M. Horowitz, 2007, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

A randomized multicenter comparison of bone marrow and peripheral blood in recipients of matched sibling allogeneic transplants for myeloid malignancies.

T. Panzarella, J. Lipton, P. Browett, 2002, Blood.

Classifying cytogenetics in patients with acute myelogenous leukemia in complete remission undergoing allogeneic transplantation: a Center for International Blood and Marrow Transplant Research study.

Alan M. Miller, P. D. Dal Cin, J. Sierra, 2012, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Association of transplant center and physician factors on mortality after hematopoietic stem cell transplantation in the United States.

J. Klein, M. Horowitz, Stephanie J. Lee, 2005, Blood.

Race and socioeconomic status influence outcomes of unrelated donor hematopoietic cell transplantation.

J. Klein, D. Friedman, K. Ballen, 2009, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Eltrombopag after allogeneic haematopoietic cell transplantation in a case of poor graft function and systematic review of the literature

D. Allan, A. Tinmouth, C. Bredeson, 2016, Transfusion medicine.

Optimal transfusion practices after allogeneic hematopoietic cell transplantation: a systematic scoping review of evidence from randomized controlled trials

D. Allan, A. Tinmouth, C. Bredeson, 2016, Transfusion.

Impact of platelet transfusion on toxicity and mortality after hematopoietic progenitor cell transplantation

H. Atkins, D. Allan, L. Huebsch, 2015, Transfusion.

Reducing the risk for transplantation-related mortality after allogeneic hematopoietic cell transplantation: how much progress has been made?

M. Pasquini, K. Ballen, H. Khoury, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

The importance of evaluating differences in HES formulations used in hematopoietic progenitor cell cryopreservation.

L. Huebsch, J. Acker, C. Bredeson, 2021, Cytotherapy.

HLA Haploidentical versus Matched Unrelated Donor Transplants with Post-Transplant Cyclophosphamide based prophylaxis.

R. Soiffer, M. Grunwald, N. Ghosh, 2021, Blood.

Major ABO-incompatible BMT: isohemagglutinin reduction with plasma exchange is safe and avoids graft manipulation

L. Huebsch, S. Mcdiarmid, C. Bredeson, 2013, Bone Marrow Transplantation.

controlled study of conditioning regimens Bone marrow transplantation for severe aplastic anemia: a randomized

J. Klein, M. Horowitz, J. Passweg, 2013 .

Comparison of outcomes after transplantation of G-CSF-stimulated bone marrow grafts versus bone marrow or peripheral blood grafts from HLA-matched sibling donors for patients with severe aplastic anemia.

B. George, R. Gale, H. Lazarus, 2011, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

American Society of Blood and Marrow Transplantation, European Society of Blood and Marrow Transplantation, Blood and Marrow Transplant Clinical Trials Network, and International Myeloma Working Group Consensus Conference on Salvage Hematopoietic Cell Transplantation in Patients with Relapsed Multip

B. Barlogie, M. Dimopoulos, H. Einsele, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Low-Dose Antithymocyte Globulin for Graft-versus-Host-Disease Prophylaxis in Matched Unrelated Allogeneic Hematopoietic Stem Cell Transplantation.

H. Atkins, D. Allan, L. Huebsch, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Transplant registries: guiding clinical decisions and improving outcomes.

M. Horowitz, C. Bredeson, F. Loberiza, 2001, Oncology.

Cost analysis of the introduction of PBPC for autologous transplantation: effect of switching from bone marrow (BM) to peripheral blood progenitor cells (PBPC)

L. Huebsch, C. Bredeson, I. Bence-Bruckler, 1997, Bone Marrow Transplantation.

Long-term graft function following autologous hematopoietic cell transplantation and the impact of preemptive plerixafor in predicted poor mobilizers

D. Allan, L. Huebsch, S. Mcdiarmid, 2018, Blood Cancer Journal.

Performance status, but not the Hematopoietic Cell Transplantation Comorbidity Index (HCT-CI), predicts mortality at a Canadian transplant center

C. Bredeson, D. Szwajcer, M. Seftel, 2009, Bone Marrow Transplantation.

Comparison of complication rates and incidences associated with different peripherally inserted central catheters (PICC) in patients with hematological malignancies: a retrospective cohort study

E. Sabri, S. Mcdiarmid, C. Bredeson, 2020, Leukemia & lymphoma.

Current trends in clinical studies of allogeneic hematopoietic stem cell transplantation.

D. Allan, C. Bredeson, J. Tay, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Autologous stem cell transplantation in multiple myeloma patients <60 vs ⩾60 years of age

S. Jagannath, R. Kyle, J. Wingard, 2003, Bone Marrow Transplantation.

The Concentration of Total Nucleated Cells in Harvested Bone Marrow for Transplantation Has Decreased over Time.

M. Norkin, J. Szer, J. Liesveld, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

HLA-matched sibling bone marrow transplantation for (cid:1) -thalassemia major

M. Chandy, R. Gale, A. Ghavamzadeh, 2011 .

Immunoablation and autologous haemopoietic stem-cell transplantation for aggressive multiple sclerosis: a multicentre single-group phase 2 trial

D. Arnold, H. Atkins, A. Bar-Or, 2016, The Lancet.

Effect of Donor Age and Donor Relatedness on Time to Allogeneic Hematopoietic Cell Transplantation in Acute Leukemia.

H. Atkins, D. Allan, L. Huebsch, 2018, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Peripheral blood stem cells or bone marrow as the graft source for allogeneic hematopoietic cell transplantation

C. Bredeson, T. Alwasaidi, 2014 .

Allogeneic Hematopoietic Cell Transplantation as Curative Therapy for Patients with Non-Hodgkin Lymphoma: Increasingly Successful Application to Older Patients.

A. Evens, E. Petersdorf, H. Lazarus, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Maintenance Therapies for Hodgkin and Non-Hodgkin Lymphomas After Autologous Transplantation: A Consensus Project of ASBMT, CIBMTR, and the Lymphoma Working Party of EBMT

J. Vose, S. Montoto, Sonali M. Smith, 2019, JAMA oncology.

Allogeneic Hematopoietic Cell Transplantation for Adult Chronic Myelomonocytic Leukemia.

J. Cortes, M. Aljurf, M. Tallman, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Clinical Practice Recommendations for Use of Allogeneic Hematopoietic Cell Transplantation in Chronic Lymphocytic Leukemia on Behalf of the Guidelines Committee of the American Society for Blood and Marrow Transplantation.

J. Gribben, E. Montserrat, F. Awan, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Autologous hemopoietic stem cell transplantation in severe rheumatoid arthritis: a report from the EBMT and ABMTR.

P. Brooks, P. Emery, J. Snowden, 2004, The Journal of rheumatology.

Comparison of outcomes of allogeneic transplantation for chronic myeloid leukemia with cyclophosphamide in combination with intravenous busulfan, oral busulfan, or total body irradiation.

J. Cortes, M. Aljurf, J. Szer, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Better leukemia-free and overall survival in AML in first remission following cyclophosphamide in combination with busulfan compared with TBI.

J. Cortes, M. Aljurf, J. Szer, 2013, Blood.

Impacts of Cytogenetic Abnormalities and Prior Alemtuzumab on Outcomes of Patients (pts) with High-Risk Chronic Lymphocytic Leukemia (CLL) Given Nonmyeloablative Allogeneic Hematopoietic Cell Transplantation (HCT)

M. Sorror, R. Storb, B. Sandmaier, 2010 .

Non‐myeloablative allogeneic haematopoietic cell transplantation for relapsed diffuse large B‐cell lymphoma: a multicentre experience

M. Sorror, R. Storb, B. Sandmaier, 2008, British journal of haematology.

Does Lymphocyte Count Impact Dosing of Anti-Thymocyte Globulin in Unrelated Donor Stem Cell Transplantation?

H. Atkins, D. Allan, L. Huebsch, 2020, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

with TBI following cyclophosphamide in combination with busulfan compared Better leukemia-free and overall survival in AML in first remission

J. Cortes, M. Aljurf, J. Szer, 2013 .

Association of depressive syndrome and early deaths among patients after stem-cell transplantation for malignant diseases.

M. Horowitz, J. Weeks, Stephanie J. Lee, 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

MYELOABLATIVE ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION IN PATIENTS WHO RELAPSE AFTER AUTOLOGOUS STEM CELL TRANSPLANTATION FOR LYMPHOMA: A REPORT OF THE INTERNATIONAL BONE MARROW TRANSPLANT REGISTRY Running head: Allogeneic transplants after autologous failure For Submission to BLOOD, Trans

J. Vose, M. Horowitz, R. Gale, 2004 .

Inferior Outcomes with Cyclosporine and Mycophenolate mofetil after Myeloablative Allogeneic Hematopoietic Cell Transplantation.

M. Aljurf, R. Gale, J. Pidala, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Outpatient total body irradiation as a component of a comprehensive outpatient transplant program

H. Atkins, C. Martens, L. Huebsch, 2002, Bone Marrow Transplantation.

Out-Patient Blood and Marrow Transplantation

C. Bredeson, 1998 .

Neurocognitive dysfunction in hematopoietic cell transplant recipients: expert review from the late effects and Quality of Life Working Committee of the CIBMTR and complications and Quality of Life Working Party of the EBMT

M. Norkin, A. Nagler, J. Szer, 2018, Bone Marrow Transplantation.

Use of biological assignment in hematopoietic stem cell transplantation clinical trials

E. Leifer, N. Geller, B. Logan, 2008, Clinical trials.

Is cytomegalovirus testing of blood products still needed for hematopoietic stem cell transplant recipients in the era of universal leukoreduction?

D. Allan, L. Huebsch, S. Mcdiarmid, 2013, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

The Impact of Graft-versus-Host Disease on the Relapse Rate in Patients with Lymphoma Depends on the Histological Subtype and the Intensity of the Conditioning Regimen.

S. Montoto, Sonali M. Smith, J. Klein, 2015, Biology of Blood and Marrow Transplantation.

Autologous or allogeneic stem cell transplantation in patients with Waldenstrom's macroglobulinemia.

H. Goldschmidt, P. Hari, D. Reece, 2006, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Outcomes of Allogeneic Hematopoietic Cell Transplantation in T-cell Prolymphocytic Leukemia: A Contemporary Analysis from the Center for International Blood and Marrow Transplant Research.

J Wagner, F. Awan, M. Krem, 2022, Transplantation and cellular therapy.

Extracorporeal photopheresis in the management of graft-versus-host disease.

J. Kuruvilla, R. B. Rumble, C. Bredeson, 2014, Current oncology.

Primary preventative care of hematopoietic stem cell transplant survivors: time to educate and empower recipients and providers.

Alexandre P. Blanchard, C. van Walraven, C. Bredeson, 2022, Transplantation and cellular therapy.

hematopoietic stem cell transplantation in the United States Association of transplant center and physician factors on mortality after

J. Klein, M. Horowitz, Stephanie J. Lee, 2011 .

J. Sierra, M. Tallman, R. Gale, 2008, Blood.

Systemic mastocytosis emerging after azacitidine treatment of refractory anaemia with excess blasts type 2

C. Bredeson, D. Sheppard, M. Sabloff, 2014, British Journal of Haematology.

Considerations when designing a clinical trial of haematopoietic stem cell transplantation for autoimmune disease.

C. Bredeson, S. Pavletic, 2004, Best practice & research. Clinical haematology.

Intermittent zoledronic Acid prevents bone loss in adults after allogeneic hematopoietic cell transplantation.

P. Hari, D. Vesole, C. Bredeson, 2013, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Primary care for recipients of allogeneic hematopoietic stem cell transplantation

C. Bredeson, S. Hertz, J. Fulcher, 2020, Canadian Medical Association Journal.

Relapse and Disease-Free Survival in Patients With Myelodysplastic Syndrome Undergoing Allogeneic Hematopoietic Cell Transplantation Using Older Matched Sibling Donors vs Younger Matched Unrelated Donors.

R. Vij, M. Aljurf, R. Gale, 2022, JAMA oncology.

Pre-transplant marital status and hematopoietic cell transplantation outcomes.

W. Wood, K. Sullivan, M. Aljurf, 2020, Current oncology.

Peripheral Blood versus Bone Marrow from Unrelated Donors: Bone Marrow Allografts Have Improved Long-Term Overall and Graft-versus-Host Disease-Free, Relapse-Free Survival.

J. Kanda, R. Gale, J. Pidala, 2019, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Alternative donor transplantation for myelodysplastic syndromes: haploidentical relative and matched unrelated donors.

B. George, M. Grunwald, D. Weisdorf, 2021, Blood advances.

Improved Prediction of CD34+ Cell Yield before Peripheral Blood Hematopoietic Progenitor Cell Collection Using a Modified Target Value-Tailored Approach.

D. Allan, L. Huebsch, S. Mcdiarmid, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Autologous Hematopoietic Stem Cell Transplantation for Chronic Inflammatory Demyelinating Polyradiculoneuropathy

H. Atkins, D. Allan, L. Huebsch, 2021, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

lymphoblastic leukemia in first complete remission Unrelated donor transplants in adults with Philadelphia-negative acute

J. Sierra, R. Gale, M. Bishop, 2011 .

High-dose therapy and autologous hematopoietic stem cell transplantation for patients with primary systemic amyloidosis: a Center for International Blood and Marrow Transplant Research Study.

D. Reece, D. Vesole, C. Bredeson, 2006, Mayo Clinic proceedings.

A Portrait of SARS-CoV-2 Infection in Patients Undergoing Hematopoietic Cell Transplantation: A Systematic Review of the Literature

D. Allan, C. Bredeson, R. Shorr, 2022, Current oncology.

Duration of first remission and hematopoietic cell transplantation-specific comorbidity index but not age predict survival of patients with AML transplanted in CR2: a retrospective multicenter study

E. Atenafu, C. Bredeson, J. Finke, 2016, Bone Marrow Transplantation.

Association of Reduced-Intensity Conditioning Regimens With Overall Survival Among Patients With Non-Hodgkin Lymphoma Undergoing Allogeneic Transplant.

M. Aljurf, L. Lekakis, N. Ghosh, 2020, JAMA oncology.

Does location matter? Rural vs urban outcomes after blood and marrow transplantation in a population-based Canadian cohort

C. Bredeson, D. Szwajcer, M. Seftel, 2010, Bone Marrow Transplantation.

K. Ballen, H. Lazarus, L. Isola, 2008 .

Total body irradiation (18 Gy) without chemotherapy as conditioning for allogeneic hematopoietic cell transplantation in refractory acute myeloid leukemia

H. Atkins, D. Allan, T. Ramsay, 2020, Bone Marrow Transplantation.

Treatment of acute promyelocytic leukemia in patients presenting at Vancouver General Hospital from 1983 to 1992.

D. Horsman, J. Spinelli, D. Reece, 1995, Leukemia & lymphoma.

Selecting the optimal targeted therapy for relapsed B-acute lymphoblastic leukemia

E. Leung, C. Bredeson, M. Sabloff, 2020, Leukemia & lymphoma.

First-line therapy, autologous stem-cell transplantation, and post-transplantation maintenance in the management of newly diagnosed mantle cell lymphoma.

S. Bhella, M. Crump, G. Fraser, 2020, Current oncology.

Comparison of Characteristics and Outcomes of Trial Participants and Nonparticipants: Example of Blood and Marrow Transplant Clinical Trials Network 0201 Trial.

W. Wood, M. Aljurf, M. Horowitz, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Are We Choosing Wisely With Autologous Hematopoietic Cell Transplantation Screening? The Utility of Pulmonary Function Testing Prior to Autologous Hematopoietic Cell Transplantation

D. Allan, L. Huebsch, C. Bredeson, 2019, Clinical lymphoma, myeloma & leukemia.

J. Klein, K. Sullivan, R. Gale, 2007, British journal of haematology.

Gastric Antral Vascular Ectasia and Its Clinical Correlates in Patients with Early Diffuse Systemic Sclerosis in the SCOT Trial

M. Mayes, K. Sullivan, D. Furst, 2013, The Journal of Rheumatology.

Comparison of Allogeneic Hematopoietic Cell Transplantation Outcomes from Younger Matched Unrelated Donor Versus Older Sibling Donor for Acute Myeloid Leukemia

D. Allan, C. Bredeson, W. Saber, 2022, Blood.

2 ‐Chloro‐deoxyadenosine therapy for giant lymph node hyperplasia

C. Bredeson, L. Bordeleau, S. Markman, 1995, British Journal of Haematology.

Second transplant for acute and chronic leukemia relapsing after first HLA-identical sibling transplant

M. Tallman, O. Ringdén, R. Martino, 2004, Bone Marrow Transplantation.

Heterogeneity in studies of mesenchymal stromal cells to treat or prevent GVHD: a scoping review of the evidence.

D. Allan, C. Bredeson, N. Kekre, 2016 .

Evaluation of an Outpatient Model for Treatment of Acute Myeloid Leukemia

H. Atkins, D. Allan, T. Ramsay, 2016 .

CAR-T Cells in Canada; Perspective on How to Ensure We Get Our Value’s Worth

C. Bredeson, P. Villeneuve, 2023, Current oncology.

Autologous versus reduced-intensity allogeneic hematopoietic cell transplantation for patients with follicular non-hodgkins lymphoma (FL) beyond first complete response or first partial response

J. Vose, J. Klein, M. Horowitz, 2008 .

Denials Of Treatment Coverage By Health Insurance Carriers Restrict Patient Recruitment On A Randomized Clinical Trial: Experience Of 95 Patients With Systemic Sclerosis (SSc) Enrolled In The SCOT (Scleroderma: Cyclophosphamide Or Transplantation) Trial

M. Mayes, W. Clair, K. Sullivan, 2010 .

Use of a disease-specific decision aid to determine the minimal clinically important difference between autologous bone marrow transplantation versus standard salvage therapy for patients with high-risk low-grade non-Hodgkin's lymphoma.

C. Bredeson, 1997 .

What is the optimal approach to major ABO-incompatible allogeneic stem cell transplantation?

L. Huebsch, C. Bredeson, D. Sheppard, 2013, Biology of Blood and Marrow Transplantation.

Pulmonary toxicity following total body irradiation for acute lymphoblastic leukaemia: The Ottawa Hospital Cancer Centre (TOHCC) experience

C. Bredeson, R. Ujaimi, R. Samant, 2015, Journal of Radiotherapy in Practice.

Pulmonary Toxicity Following Total Body Irradiation for Acute Lymphoblastic Leukemia: The Ottawa Hospital Cancer Centre (TOHCC) Experience

C. Bredeson, R. Ujaimi, R. Samant, 2013 .

Improved Survival with Intravenous Busulfan (IV BU) Compared to Total Body Irradiation (TBI)-Based Myeloablative Conditioning Regimens: A CIBMTR Prospective Study

M. Pasquini, Xiaochun Zhu, P. McCarthy, 2013 .

Early warning of infection in patients undergoing hematopoietic stem cell transplantation using heart rate variability and serum biomarkers.

A. Seely, C. Herry, L. Huebsch, 2021, Transplantation and cellular therapy.

Impact of Donor Age on Allogeneic Hematopoietic Cell Transplantation Outcomes in Older Adults with Acute Myeloid Leukemia.

C. Hourigan, M. Aljurf, C. Bredeson, 2023, Transplantation and cellular therapy.

Younger Matched Unrelated Donors Confer Decreased Relapse Compared to Older Sibling Donors in Older B-cell ALL Patients Undergoing Allogeneic Hematopoietic Cell Transplantation.

C. Hourigan, C. Bredeson, D. Marks, 2023, Transplantation and cellular therapy.

A national survey of screening and management of hypogammaglobulinemia in Canadian transplantation centers

G. Knoll, C. Bredeson, J. Tay, 2017, Transplant infectious disease : an official journal of the Transplantation Society.

Long-term graft function following autologous hematopoietic cell transplantation and the impact of preemptive plerixafor in predicted poor mobilizers

D. Allan, L. Huebsch, S. Mcdiarmid, 2018, Blood Cancer Journal.

Selection of appropriate venous access for the collection of peripheral blood progenitor cells by experienced apheresis nurses

L. Huebsch, S. Mcdiarmid, C. Bredeson, 1999, Journal of clinical apheresis.

Breaking the Age Barrier: Physicians' Perceptions on Candidacy for Allogeneic Hematopoietic Cell Transplantation in Older Adults.

W. Wood, M. Sorror, D. Howard, 2021, Transplantation and cellular therapy.

Nonmyeloablative Allogeneic Hematopoietic Cell Transplantation in Patients with De Novo and Secondary Acute Myeloid Leukemia

M. Maris, R. Storb, B. Sandmaier, 2008 .

A simple prognostic system in patients with myelofibrosis undergoing allogeneic stem cell transplantation: a CIBMTR/EBMT analysis

I. Yakoub-Agha, M. Aljurf, R. Gale, 2023, Blood advances.

What is the optimal approach to major ABO-incompatible allogeneic stem cell transplantation?

L. Huebsch, C. Bredeson, D. Sheppard, 2013, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Better leukemia-free and overall survival in AML in first remission following cyclophosphamide in combination with busulfan compared with TBI.

J. Cortes, M. Aljurf, J. Szer, 2013, Blood.

Conditioning regimens for allotransplants for diffuse large B-cell lymphoma: myeloablative or reduced intensity?

J. Vose, Sonali M. Smith, P. Hari, 2012, Blood.

Peripheral-blood stem cells versus bone marrow from unrelated donors.

P. Westervelt, S. Mineishi, D. Porter, 2012, The New England journal of medicine.

J. Wingard, B. Shaw, H. Lazarus, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

The Impact of Graft-versus-Host Disease on the Relapse Rate in Patients with Lymphoma Depends on the Histological Subtype and the Intensity of the Conditioning Regimen.

S. Montoto, Sonali M. Smith, D. Maloney, 2015, Biology of Blood and Marrow Transplantation.

Peripheral Blood versus Bone Marrow from Unrelated Donors: Bone Marrow allografts have improved Long-term Overall and Graft-versus-Host Disease, Relapse-Free Survival Biol Blood Marrow Transplant.

J. Kanda, J. Pidala, M. Boyiadzis, 2019 .

A. Krishnan, S. Lonial, Shaji K. Kumar, 2015, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Intravenous Busulfan-Based Myeloablative Conditioning Regimens Prior to Hematopoietic Cell Transplantation for Hematologic Malignancies.

J. Mehta, J. Dipersio, S. Mineishi, 2016, Biology of Blood and Marrow Transplantation.

Intravenous versus oral busulfan-based conditioning for pediatric allogeneic hematopoietic cell transplantations: did the pendulum swing too far, too fast?

C. Bredeson, 2013, Biology of Blood and Marrow Transplantation.

Prospective cohort study comparing intravenous busulfan to total body irradiation in hematopoietic cell transplantation.

J. Dipersio, F. Appelbaum, M. Pasquini, 2013, Blood.

Intravenous Busulfan Compared with Total Body Irradiation Pretransplant Conditioning for Adults with Acute Lymphoblastic Leukemia.

M. Norkin, R. Vij, W. Wood, 2017, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Risk-Factors for Acute Graft-Versus-Host Disease and Survival After Hematopoietic Cell Transplantation From Siblings and Unrelated Donors – An Analysis of the CIBMTR

M. Horowitz, R. Gale, Stephanie J. Lee, 2010 .

Indications and Results of HLA-Identical Sibling Hematopoietic Cell Transplantation for Sickle Cell Disease.

D. Neuberg, K. Sullivan, E. Petersdorf, 2016, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

Outcomes with low dose anti-thymocyte globulin based graft versus host disease prophylaxis after mismatched unrelated donor allogeneic hematopoietic cell transplantation.

C. Bredeson, Hafsah Chalchal, Vinita Dhir, 2024, European Journal of Haematology.